Related Experiment Video
Updated: Jun 15, 2026

Colonization with Murine pks+ Escherichia coli under Non-Inflammatory Conditions
Published on: March 10, 2026
Intercontinental spread from Israel to Colombia of a KPC-3-producing Klebsiella pneumoniae strain
J A Lopez1, A Correa, S Navon-Venezia
1Hospital Pablo Tobón Uribe, Medellín, Colombia.
Abstract:
In 2008, an increase in the prevalence of carbapenem-resistant Klebsiella pneumoniae was noted in a 286-bed tertiary case hospital in Colombia, where 84 patients (32 infected and 52 colonized) had positive cultures. The identified index patient came from Israel for a liver transplantation. High level carbapenem resistance was observed. Polymyxin B and tigecycline were the only two antibiotics that remained active. PCR-restriction fragment length polymorphism analysis and sequencing revealed blaKPC-3 in the major clone, which was indistinguishable from the K. pneumoniae carbapenemase-3-producing clone described previously in Israel. This exemplifies the threat posed by the global spread of K. pneumoniae carbapenemase-producing pathogens.
Insights
A carbapenem-resistant Klebsiella pneumoniae (CRKP) outbreak occurred in Colombia in 2008, linked to an international liver transplant patient. This highlights the global threat of carbapenemase-producing CRKP spread.
Area of Science:
- Microbiology
- Infectious Diseases
- Epidemiology
Background:
- Klebsiella pneumoniae is a significant nosocomial pathogen.
- Carbapenem resistance in K. pneumoniae is a growing global health concern.
- The emergence of K. pneumoniae carbapenemase (KPC) is particularly alarming.
Observation:
- An increase in carbapenem-resistant Klebsiella pneumoniae (CRKP) cases was observed in a Colombian hospital in 2008.
- Eighty-four patients were culture-positive for CRKP, including infected and colonized individuals.
- The index case involved a patient who traveled from Israel for liver transplantation.
Findings:
- High-level carbapenem resistance was detected in the identified K. pneumoniae isolates.
- Polymyxin B and tigecycline were the only effective antibiotics against the resistant strains.
- Genetic analysis identified the blaKPC-3 gene in the predominant clone, matching a previously described clone from Israel.
Implications:
- This event underscores the rapid international dissemination of carbapenemase-producing K. pneumoniae.
- It highlights the critical need for robust infection control measures in healthcare settings.
- The findings emphasize the threat posed by KPC-producing pathogens to global public health.
More Related Videos
09:44Characterization of a Pathogenic Escherichia coli Strain Derived from Oreochromis spp. Farms Using Whole-Genome Sequencing
Published on: December 23, 2022
08:23Culture Methods to Determine the Limit of Detection and Survival in Transport Media of Campylobacter Jejuni in Human Fecal Specimens
Published on: March 10, 2020
Related Concept Videos
Colonisation of Pathogens
Bacterial Gastroenteritis
Reservoir of Infection
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Stringent Response in E. coli
Rapid Identification of Pathogens